![Athena Countouriotis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Athena Countouriotis
Direktor/Vorstandsmitglied bei
BIOMARIN PHARMACEUTICAL INC.
Vermögen: 1 Mio $ am 30.06.2026
Profil
Athena Countouriotis ist Mitglied des Vorstands von Iovance Biotherapeutics, Inc. und NuMedii, Inc. sowie Präsidentin, Chief Executive Officer & Director bei Turning Point Therapeutics, Inc. Dr. Countouriotis war zuvor Director-Oncology Global Clinical Research bei Bristol Myers Squibb Co, Chief Medical Officer & Senior Vice President bei Halozyme Therapeutics, Inc, Chief Medical Officer & Senior Vice President bei Adverum Biotechnologies, Inc, Associate Medical Director bei CTI BioPharma Corp. und Chief Medical Officer bei Ambit Biosciences Corp. Dr. Countouriotis promovierte an der Tufts University School of Medicine und erwarb einen Bachelor-Abschluss an der University of California, Los Angeles.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.06.2026 | 21 040 ( 0,01 % ) | 1 Mio $ | 30.06.2026 | |
PASSAGE BIO, INC. 0,03 % | 19.05.2026 | 945 ( 0,03 % ) | 4 612 $ | 30.06.2026 |
| 16.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktuelle Nachrichten zu Athena Countouriotis
Aktive Positionen von Athena Countouriotis
| Unternehmen | Position | Beginn |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.06.2019 |
| PASSAGE BIO, INC. | Direktor/Vorstandsmitglied | 01.02.2020 |
| BIOMARIN PHARMACEUTICAL INC. | Direktor/Vorstandsmitglied | 27.12.2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Vorstandsvorsitzender | - |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Vorsitzender | 12.10.2022 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Vorsitzender | 12.09.2022 |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies | Direktor/Vorstandsmitglied | 20.06.2018 |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops neuro-metabolic therapies for CNS disorders | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Athena Countouriotis
| Unternehmen | Position | Ende |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 24.01.2020 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Athena Countouriotis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies | Commercial Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
Leal Therapeutics, Inc.
Leal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops neuro-metabolic therapies for CNS disorders | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
